Article Details

Excision BioTherapeutics Completes $60 Million Financing to Advance CRISPR-Based Infectious ...

Retrieved on: 2021-02-17 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Excision BioTherapeutics Completes $60 Million Financing to Advance CRISPR-Based Infectious .... View article details on hiswai:

Excerpt

New investors include Adjuvant Capital, Norwest Venture Partners, Anzu Partners, Cota Capital, WRVI Capital, IndusAge Partners, Loreda Holdings, ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up